Provided by Tiger Trade Technology Pte. Ltd.

Mirum Pharmaceuticals, Inc.

100.61
+2.312.35%
Pre-market: 100.800.1900+0.19%07:46 EDT
Volume:587.04K
Turnover:58.50M
Market Cap:6.53B
PE:-7.15
High:101.18
Open:98.30
Low:97.48
Close:98.30
52wk High:130.00
52wk Low:63.23
Shares:64.93M
Float Shares:56.42M
Volume Ratio:1.19
T/O Rate:1.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.0800
EPS(LYR):-0.4700
ROE:-702.97%
ROA:-6.79%
PB:-626.83
PE(LYR):-214.06

Loading ...

Mirum Pharmaceuticals Names Rob Myers Chief Medical Officer Effective Sept. 21, 2026

Reuters
·
Sep 08

Mirum Pharmaceuticals Appoints DR. Rob Myers as Chief Medical Officer

THOMSON REUTERS
·
Sep 08

Mirum CEO Christopher Peetz Sells 30,000 Shares for $2.95 Million

Reuters
·
Sep 04

Mirum Pharmaceuticals to Present at Cantor Global Healthcare Conference

Reuters
·
Sep 03

Mirum Pharmaceuticals (MIRM) Could Be 32% Undervalued After Recent Performance Metrics

Simply Wall St.
·
Sep 02

Mirum Pharmaceuticals (MIRM) Following Rare Disease Growth Narrative Looks Undervalued

Simply Wall St.
·
Aug 25

Mirum Pharma SVP, Global Controller Jolanda Howe Disposes of 40,000 Common Shares for $4 Million

Reuters
·
Aug 20

Will Mirum Pharmaceuticals' (MIRM) Widening Net Losses Test Its Growth-Focused Investment Narrative?

Simply Wall St.
·
Aug 16

Mirum Pharmaceuticals CEO Christopher Peetz Melepas Saham Senilai $1,99 Juta

Reuters
·
Aug 12

Mirum Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule

Reuters
·
Aug 12

Mirum Pharmaceuticals Laporkan Hibah Inducement 26.050 Opsi Saham Dan 34.590 RSU Untuk 19 Karyawan Baru

Reuters
·
Aug 12

J.P. Morgan Keeps Their Buy Rating on Mirum Pharmaceuticals (MIRM)

TIPRANKS
·
Aug 11

Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (MIRM) and Encompass Health (EHC)

TIPRANKS
·
Aug 10

Ardelyx Says Q2 Product Revenue at Record High but Ibsrela Revenue Below Expectations

Reuters
·
Aug 07

BioMarin Q2 Revenue Beats Estimates; Raises 2026 Outlook

Reuters
·
Aug 07

Mirum sinks after FDA recommends conducing Phase 3 study

TIPRANKS
·
Aug 07

Mirum Pharmaceuticals is Maintained at Market Outperform by Citizens

Dow Jones
·
Aug 06

Mirum Pharmaceuticals, Inc. : Raymond James Raises Target Price to $183 from $165

THOMSON REUTERS
·
Aug 06

Mirum Pharmaceuticals price target lowered to $137 from $146 at Citizens

TIPRANKS
·
Aug 06

Mirum Pharmaceuticals, Inc. : JP Morgan Cuts Target Price to $118 from $125

THOMSON REUTERS
·
Aug 06